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Background: Probiotic products that may modify the intestinal microbiota are becoming increasingly available and
known to consumers due to their potential to prevent or treat many pediatric health conditions. As scientific
knowledge of the health benefits of probiotics increases, it is important to identify factors that may prevent their
successful integration into patient care as well as to ensure effective translation of research findings. The aim of this
study was to describe maternal perspectives on probiotics and their use in infants.
Methods: Mothers with a child aged two years or younger enrolled in the Alberta Pregnancy Outcomes and
Nutrition (APrON) study were invited by email to complete a 29 item self-administered web-based questionnaire.
Results: A total of 413 mothers of the 1327 contacted completed the questionnaire. The majority (99.3%) of
respondents had heard of probiotics and were aware that they contained live bacteria (87.0%); 89.3% had used a
product containing probiotics themselves but only 50.8% had given one to their infant. Most mothers indicated
they believed that probiotics were beneficial (73.1%) and none thought they were harmful. Over a third of mothers
did not feel informed enough to make a decision on whether probiotics were safe to use in infants (36.6%).
Conclusions: The study demonstrates that awareness and understanding of probiotics is high among mothers in
Alberta, Canada. However, there is still uncertainty regarding the benefit of probiotics as well as safety in infants
which could be important factors determining therapeutic use in the future. Further studies that demonstrate
beneficial effects and safety of probiotics in healthy infants as well as targeted knowledge translation should help
to address these potential concerns.
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Due to the association between the intestinal microbiota
and human health [1-3], attention has focused on prod-
ucts that can beneficially manipulate the microbiota
profile. Probiotics are commonly defined as live microor-
ganisms, which when administered in adequate amounts
confer a health benefit on the host [4]. To date, a large
number of studies have been conducted to assess the
potential beneficial effect of probiotics in the treatment
and prevention of pediatric disease, including acute
gastroenteritis, antibiotic associated diarrhea, necrotizing
enterocolitis (NEC), constipation, allergic disease, colic and
respiratory infections [5]. A recent review of the evidence* Correspondence: kozyrsky@ualberta.ca
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unless otherwise stated.by the Canadian Paediatric Society states that physicians
should consider the use of probiotics in infants for the
prevention of antibiotic-associated diarrhea, treatment of
acute diarrhea, in the prevention of NEC in preterm in-
fants and to decrease symptoms of colic and irritable bowel
syndrome [6]. In contrast, other reviews have concluded
that while a number of randomized controlled trials dem-
onstrate encouraging results, clear clinical benefits of pro-
biotics for prevention of disease in infants is not yet
convincing [5,7,8].
Efficacy of probiotics depends on the species and
strain of bacteria, as well as the dosage and length of
administration. Heterogeneity in these variables among
studies as well as inadequacies in study design has
likely contributed to the conflicting outcomes in pro-
biotic studies to date, hampering their translation intoral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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several concerns exist regarding the use of probiotics
in infants due to their immature gastrointestinal and
immune systems. Although extremely rare, probiotic
bacteria have the potential to translocate through the
gut epithelium and cause bacteraemia or sepsis [11].
The long term effect of administration of bacterial
strains during the early development of the gut micro-
biota is also unknown. A recent study evaluating the
safety of probiotics used in young children aged 0 –
2 years found no major safety concerns but highlighted
that inconsistent and incomplete reporting of adverse
events in studies and variation of strains and dosage used
limit the generalizability of conclusions [12]. Overall,
although predominantly deemed safe for use in healthy
term infants, there is a consensus that more strain-
specific safety data in this population group is needed, as
well as evidence on longer term effects [5,8,12,13].
In many countries, probiotics are categorized as foods
or dietary supplements rather than medicines and there-
fore can be readily purchased in grocery and health food
stores without a prescription or professional advice.
There is growing availability of probiotic products mar-
keted for infants and young children which include
yogurts, liquid supplements and weaning foods. Probiotics
are also now included in a number of infant formulae
worldwide as evidence of the presence of live bacteria in
breast milk increases [14].
Given the recent scientific attention, coupled with the
increasing availability of probiotic products, it is import-
ant that practitioners have an understanding of patient
knowledge and opinions surrounding probiotics, as well as
their current use in infants to enable effective translation
of research knowledge as it becomes available. The aim of
this cross-sectional survey of mothers was to ascertain ex-
tent of probiotic use in infants, and maternal knowledge
and opinions on their safety and effectiveness.
Methods
Study subjects
Mothers were recruited via email from the Alberta
Pregnancy Outcomes and Nutrition (APrON) cohort
study. APrON is an ongoing prospective general birth co-
hort of pregnant women and their infants from Calgary
and Edmonton, Alberta (Western Canada) [15]. In Calgary,
women were enrolled in APrON primarily through pre-
natal clinics, although community advertising and media
coverage were also used. Due to differences in obstetrical
care between the cities, women in Edmonton were re-
cruited primarily through local media coverage, paid
advertising and recruitment tables at shopping malls,
recreational centres and community fairs. An APrON
webpage was also used to recruit participants in both cit-
ies. After women expressed interest in the study, APrONresearch assistants contacted prospective participants to
describe the study in more detail. Pregnant women over
the age of 16 years with a gestation <27 weeks, and living
in or near Calgary or Edmonton were eligible. Women
were excluded if they were unable to answer questions in
English or if they planned to move out of the region dur-
ing the timeframe of the study. Mothers in APrON are
self-reported to be primary caregivers of their infants.
For the current survey, mothers were eligible for inclu-
sion if they had a child aged two years or younger en-
rolled in APrON at the time of the survey administration
and had given consent to be contacted about other stud-
ies outside of APrON.
Survey
The self-administered web-based survey consisted of 29
questions in themed sections. We report here on re-
sponses to 9 questions relating to maternal awareness of
probiotics, use in self and infants, as well as opinions
surrounding probiotic use in infants. Standard demo-
graphic information was also captured as part of the
survey. The survey was constructed and validated by six
researchers in child health with expertise in microbiota
research, nutrition, psychology, ethics and questionnaire
design. It was subsequently piloted on 5 pregnant women
or new mothers to verify understanding; pilot testing re-
sulted in minor changes to the wording of some questions.
The survey was conducted using Checkbox® v4.7, hosted
on a secure server at the University of Alberta and was
completed anonymously. Mothers who completed the sur-
vey were entered into a lottery prize draw to win a gift
card. An email reminder was sent approximately 3 weeks
after the initial invitation to encourage participation.
Ethical considerations
The research protocol and all study materials and incen-
tives were approved by the Health Research Ethics Board
of the University of Alberta and the Cojoint Health
Research Ethics Board at the University of Calgary.
Consent was obtained from all participants before comple-
tion of the survey.
Data analysis
Frequencies were compiled for all variables. Chi-square
analysis was used to determine the association between
use of probiotics in infants, sociodemographic charac-
teristics and maternal opinions of probiotic benefit
and safety. Mean differences in maternal opinion on
safety across groups of commonly used products in in-
fancy, including probiotics, was tested using the non-
parametric version of repeated-measures analysis of
variance (Friedman Test) with post hoc Wilcoxon signed-
rank tests to further explore differences in perceived safety
between probiotics specifically and all other food/products.
Table 1 Characteristics of survey participants
Demographic variables %




Marital Status (N = 389)
Married 86.9
Common-law/Living with partner 10.0
Single/Separated/Divorced/Widowed 3.1
Highest Level of Education (N = 389)










$100,000 or more 57.1
Children (under 18 yrs) in the Household ( N = 389 mean ± SD) 1.6 (±0.72)
Age of youngest child in months (N = 388 mean ± SD) 11.8 (±6.59)
Ethnic origin (N = 383)













Bridgman et al. BMC Complementary and Alternative Medicine 2014, 14:366 Page 3 of 9
http://www.biomedcentral.com/1472-6882/14/366The Wilcoxon signed rank test was used to explore differ-
ences in the intended use of probiotics based on a number
of hypothetical scenarios of health effects compared to
intention to use if no health effects were demonstrated.
Responses to open questions were hand coded into
relevant themes to enable reporting of frequencies.
Statistical analysis was performed using IBM SPSS
Statistics for Windows version 21.0
Results
During April 2012, 1327 women who had enrolled in
the APrON cohort study between September 2009 and
December 2011 were invited by email to participate in
the survey. Of the 1327 contacted, 426 subjects followed
the link to the survey consent and information page. In the
final analysis, 13 subjects were excluded (two did not give
consent; 11 gave consent but did not complete any of the
questions). In total, 413 mothers completed the survey
after giving consent, representing a response rate of 31%.
The characteristics of the mothers are presented in
Table 1. The majority were 25 years of age or older
(98.5%), married (86.9%), had completed a university de-
gree or higher (77.9%), had a total household income of
over $70,000 (83.5%), were of European origin (74.7%)
and were born in Canada (82.2%). They were representa-
tive of the APrON cohort in age, household income,
marital status and place of birth; however, our sample
contained a larger proportion of more highly educated
mothers (93.1 vs 88.3% respectively held a trade, tech-
nical or higher degree). The mean age of the youngest
child in the household at the time the survey was com-
pleted was 11.8 months.
Use of probiotic products
A large proportion of mothers reported that they had
personally used probiotic products (89.3%) (Table 2).
The most cited reason for using probiotics was hearing
about them via the media or internet (43.3%). One in
five mothers (20.3%) used them on recommendation
from a healthcare professional (physician, pharmacist or
midwife) while a quarter (25.2%) used them following
recommendation by a friend.
Half of mothers reported giving a probiotic product to
their infant (50.8%). The main reasons indicated for
doing so included information from the media, recom-
mendation from a healthcare professional and/or recom-
mendation from a friend or relative (Table 2). Maternal
use of probiotics was found to be positively associated with
their use in infants (Pearson Chi-Square test P < 0.001;
OR 3.99 95%CI:1.75-9.14). There were no significant
differences in demographic characteristics (age, marital
status, education, income, ethnic origin or birth place)
between mothers that reported giving probiotic prod-
ucts to their infants and those that did not.Awareness and understanding of probiotics
Awareness of probiotics was high, with 99.3% of mothers
reporting that they had heard of the term.
Mothers were subsequently asked to provide their
own definition of probiotics (“Please describe what
you think probiotics are”). The majority (73.6%) of the
402 respondents who answered this question correctly
indicated that probiotics were or contained bacteria,
Table 2 Use of probiotics by mothers and infants and
reason for usage
Maternal (%) Infant (%)
Use of probiotics (N = 413) 89.3 50.8
Reason for usage (N = 413)a:
I read/heard about probiotics on TV/internet/
newspaper/magazine
43.3 13.6
Recommendation from friend/relative 25.2 10.7
Recommendation from physician/pharmacist 16.2 12.6
Recommendation from naturopath 12.6 5.3
Recommendation from midwife 4.1 1.9
Recommendation from lactation consultant 2.2 0.5
Probiotics have helped me in the past 20.8 4.6
Other 17.2 16.9
aParticipants were able to select more than one choice or skip the question,
therefore the percentages do not add up to 100%.
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terminology. Only a minority of mothers (4.2%) wrongly
described them as other entities such as enzymes, proteins,
plant extracts, nuts, herbal supplements or vitamins/
minerals.
Below are a selection of typical responses to the ques-
tion, “Please describe what you think probiotics are.”:
“Probiotics are micro-organisms found in things like
yogurt. They are beneficial and aid in digestion.”
“Healthy bacteria for the gut”
“Good bacteria that help with the normal functioning
of the digestive system”
“Bacteria, the good ones”
“Product that helps the healthy bacteria in your
intestines”
“Something good for you that is in some kinds of
yogurts”
The majority (88.1%) of mothers used positive words
or phrases to describe probiotics such as “good”, “benefi-
cial”, “healthy”, or provided positive health benefits that
they associated with probiotic products. None of the
mothers’ responses contained negative statements con-
cerning probiotics or their health effects. Although not
explicitly asked, many mothers also described health
benefits they believed, or had heard, to be associated
with probiotics. The most cited were benefits relating to
digestion such as “good for digestion”, “gut health”,
“maintains GI function” or other similar expressions.Figure 1 illustrates the 50 most frequent words used by
mothers to describe probiotics.
Mothers were next asked to provide their opinions on
statements about probiotics (Table 3); the vast majority
of mothers believed that probiotic products contained
live bacteria (87.0%) and that probiotics can alter a
person’s intestinal microbiota (82.8%), defined as the
bacteria in a person’s digestive system (Table 3).
Benefit and safety of probiotics
When asked to choose a statement that best described
their views of probiotics as harmful or beneficial, almost
three quarters (73.1%) of mothers believed that probio-
tics were beneficial, 9.7% of mothers had neutral views
and 15% recorded that they didn’t have enough informa-
tion to make a decision (Figure 2). No mothers indicated
that they thought probiotics were harmful. Mothers who
indicated that probiotics were beneficial were more
likely to give probiotics to their infants than those who
indicated they didn’t have enough information (Pearson
Chi-Square test P < 0.001; OR 5.94 95%CI: 3.04-11.63).
When asked, over half of the mothers were unsure if the
benefit of using probiotics in infants had been confirmed
by scientific research (66.8%), while 27.3% agreed and
5.9% disagreed (Table 3). Those agreeing were over twice
as likely to give probiotics to their infant as those dis-
agreeing or indicating that they were unsure (P < 0.001;
OR 2.42 95%CI: 1.53-3.84).
When asked for their level of agreement with the
statement “probiotics are safe to use for my baby”, over
half of mothers agreed or strongly agreed that they were
safe (55.4%) (Figure 3). Only a minority disagreed or
strongly disagreed with the statement (5.3%) while over
a third of mothers stated that they were not informed
enough to make a decision (36.6%). Mothers agreeing or
strongly agreeing to this statement were significantly
more likely to give probiotics to their infant than those
disagreeing with the statement or indicating that they
were unsure (P < 0.001; OR 14.43 95%CI: 8.82-23.59).
In a separate question, mothers were asked to rank
how safe they perceived five products to be for infants
(organic leafy green vegetables, synthetic multivitamin,
antibiotics, homeopathic remedy, probiotics). Results
showed that there was a significant difference in per-
ceived safety scores across the five products/foods (non-
parametric Friedman Test P < 0.001; Table 4). Inspection
of the mean ranks suggests that organic leafy green vege-
tables were perceived as most safe (mean rank = 1.55)
and antibiotics as least safe (mean rank = 4.06). Probiotics
were ranked second, after organic vegetables (mean
rank = 2.86). Post hoc analysis with Wilcoxon signed-rank
tests was conducted with Bonferroni correction applied
(significance level set at P < 0.0125) to test for significant
difference in perceived safety of probiotics compared to
Figure 1 Word cloud illustrating the top 50 words used to describe probiotics by mothers. Created using open access Wordle
(http://www.wordle.net/). Word size relates to frequency of use.
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significantly higher than multivitamins, antibiotics and
homeopathic remedies (P < 0.001) but lower than organic
leafy green vegetables (P < 0.001).
Intent to use probiotics based on hypothetical
health effects
To assess the potential impact of research findings on
mothers’ use of probiotics, we asked them to indicate
how likely they would be to give their infant probiotics
based on a series of hypothetical research outcomes.
Over 80% of mothers indicated that they would defin-
itely or probably give probiotics to their infant if re-
search showed that they reduced the chances of getting
a disease (Table 5). If research showed that probiotics
have no benefit to health, this number was reduced to
12.8%. When presented with information that health
benefits are uncertain and that probiotics may have
harmful effects, less than 1.5% would probably or defin-
itely give their infant probiotics, with the vast majority
stating that they would definitely not use them (63.2%).
When presented with information that giving probiotics
to infants permanently changes their microbiota, the
majority of mothers would definitely or probably notTable 3 Maternal beliefs of probiotics
Please indicate your agreement with the following statements N = 407(
Probiotics contain live bacteria
Probiotics can alter a person’s microbiota (the bacteria in a person’s digestive
The benefit/effectiveness of using probiotics in infants has been confirmed bgive probiotics to their infants (59.8%) and only a small
minority (9.2%) would definitely or probably administer
them. Results showed that mothers were significantly
more likely to use probiotics if research showed that
these products reduced the chances of their child getting
a disease (Wilcoxon signed-rank test; P < 0.001) and sig-
nificantly less likely to use probiotics if the health effects
were uncertain or may be harmful (P < 0.001), and if
probiotics were shown to permanently change an infant’s
microbiota (P = 0.01) compared to responses if research
showed probiotics to have no benefit to health.
Discussion
This cross-sectional study of 413 mothers in Alberta,
Canada indicates that awareness of probiotics is high, with
close to 90% of mothers reporting use of these products.
Despite knowing they contain live bacteria, mothers’ atti-
tudes towards probiotics in general were positive and did
not elicit any negative or harmful connotations. Many
mothers indicated that they had used probiotics themselves
and these mothers were four times more likely to have
given probiotic products to their infants.
To date, research on attitudes towards probiotics
has been limited to studies in adult populations with%) Agree Disagree Don’t know
87.0 1.7 11.3
system) 82.8 4.2 13.0
y scientific research 27.3 5.9 66.8
They are beneficial
73%













Figure 2 Maternal view of probiotics as beneficial or harmful. Mothers were asked to select the statement that best describes their view of
probiotic products.
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tary and alternative medicine use in children [18] and
most recently parental perspectives on the use of probio-
tics in preterm infants [19]. In a cross-sectional study of
children attending gastroenterology clinics in Australia,
probiotics were used by 50% of children, second only to
nutritional supplements (56%) [18]. We report here our
finding of similar high usage in our population (51%) of




Figure 3 Maternal agreement with the statement “Probiotics are safeSince the body of research on the beneficial health ef-
fects of probiotics in young children continues to grow,
characterizing mothers’ knowledge and opinions on the
use of probiotic products is important. Our study showed
that mothers rank probiotics as “safer” for infants than
other commonly used products such as vitamins, herbal
remedies and antibiotics, suggesting that mothers see pro-
biotics as relatively low-risk. The finding is comparable to






to use for my baby”.
Table 4 Comparison of maternal perception of safety of probiotics and other foods/products for use in infants
Frequency (1 =most safe; 5 = least safe) (%) Missing (%) Mean Ranka P
1 2 3 4 5
Organic leafy green vegetables 80.1 10.7 4.1 1.2 0.7 3.1 1.55 <0.001
Probiotics 18.6 41.6 28.1 6.5 1.5 3.6 2.86
Synthetic multivitamin 16.9 32.7 30 12.3 4.8 3.1 3.09
Homeopathic remedy 12.3 28.8 30.8 15.7 8.5 3.9 3.44
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therapeutic option compared to pharmaceutical treat-
ments [17]. It has been argued that the marketing of
probiotics and their widespread availability at grocery
stores reinforces this perception among consumers [20].
However, the relatively low use in infants compared to
mothers’ usage (51 vs 89%), and maternal uncertainty over
their safe use in infants suggests that mothers are more
cautious about their use in this population group or un-
sure of the benefits to their infant. Indeed, many mothers
stated that they were uncertain whether probiotic use in
infants has been proven to be beneficial by scientific re-
search. Many also indicated that they didn’t have enough
information to describe their views of probiotics or safety
for use in infants. This result is unsurprising given that
current research on benefits of probiotics in prevention
and treatment of pediatric disorders is conflicting and in
many cases not yet convincing enough to warrant health-
care recommendations.
An interesting finding from our study was that whilst
the majority of mothers acknowledged that probiotics
can alter a person’s microbiota, when presented with the
hypothetical scenario that probiotics could permanently
alter their infant’s microbiota, the majority would choose
not to use them. While a permanent change could be
“permanently beneficial”, this scenario was clearly per-
ceived as negative by mothers in the current survey.
In reality, research in both adults and older childrenTable 5 Maternal intent to use probiotics based on hypotheti
If you had another child, please indicate how likely you would be to gi
them probiotics if research showed that:
Giving babies probiotics has no benefit to their health (N = 391)
Giving babies probiotics reduces their chances of getting a disease (N = 392)
The health benefits of giving probiotics to babies is uncertain but may have harm
effects (N = 391)
Giving probiotics to babies permanently changes their microbiota (i.e. bacteria liv
in their digestive system) (N = 391)
aWilcoxon signed rank test.suggests that probiotic use only transiently alters gut
microbiota profiles [21]; however, it is plausible that ex-
posure to probiotics in infancy during this dynamic
phase of intestinal microbiota development could cause
more persistent changes. Indeed, there is evidence that
other types of early life exposures capable of disrupting
the normal development of the microbiota, such as anti-
biotic use and cesarean section delivery, can have a long
lasting impact on the gut microbiota of infants [22-25].
Although our present study was not designed to explore
this further, it will be important for other studies to in-
vestigate the underlying reasons for these views due to
their potential to limit mothers’ uptake if therapeutic
use of probiotics becomes more common in the future.
There are a number of limitations inherent to self-
administered web-based survey designs that must be
considered when interpreting the results. The most im-
portant consideration is the introduction of bias due to
non-response. Our response rate of 31%, although typ-
ical of self-administered survey designs [26], is low and
it is possible that survey respondents differ substantially
from those that did not respond. For example, individ-
uals already aware of, or using, probiotics may be more
likely to respond to the survey, thus biasing results re-
garding usage and knowledge. We were mindful of the
potential for non-response bias and took a number of
steps in the design and administration of the survey to
maximize response rates that have been shown to becal research outcomes
Likelihood to use probiotics %





2.3 10.5 28.6 39.4 19.2 ref
61.0 26.3 10.5 2.0 0.3 <0.001
ful 1.0 0.5 5.9 29.4 63.2 <0.001
ing 1.8 7.4 30.9 25.3 34.5 0.01
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sorship and use of a trusted email contact, non-monetary
incentives and reminders. Analysis of demographic char-
acteristics of respondents revealed that they were similar
in all respects to the total APrON cohort, except for level
of education. This fact, coupled with the tendency of the
general APrON cohort to over represent older, more edu-
cated mothers, may limit the generalizability of our find-
ings to the wider Canadian population. Further, we were
unable to survey fathers, who may have different perspec-
tives. Given fathers’ increasing roles in child care [29],
fathers’ perspectives need to be taken into account by
health practitioners. Finally, whilst the present study pro-
vides an initial overview of mothers’ perspectives of pro-
biotic use in infants, the design did not allow for detailed
investigation surrounding attitudes. Future qualitative
studies using in-depth interview techniques on a broader
spectrum of the population will be important to develop
greater understanding of parental use of probiotics in in-
fants and to investigate factors important for effective
knowledge translation.
Conclusions
The present cross-sectional study indicates that aware-
ness and understanding of probiotics are high among a
relatively well educated group of mothers in Alberta,
Canada. Over half of mothers had given probiotic prod-
ucts to their infants. However, for some mothers,
there is still uncertainty regarding the benefit of pro-
biotics and their safety in infants. Further studies on
the benefits and safety of probiotic use in healthy in-
fants as well as investment in the translation of re-
search findings to parents are warranted to address these
concerns.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
ALK conceptualized the study. SLB and ALK designed and coordinated
administration of the survey. MBA and BJK provided feedback on survey
questions. BJK, CJF, DWJ and NL assisted with the approval and implementation
of the study. SB analyzed the data and prepared the manuscript. All authors
reviewed, edited and approved the final manuscript.
Acknowledgements
This research was funded by the Canadian Institutes of Health Research.
APrON was funded by Alberta Innovates – Health Solutions. We thank
Pam Marples for informatics assistance with the web survey administration,
James Anderson and MSc student Alicia Pawlowski in assisting in the
survey design, Krista Gray for her involvement in coordinating the survey
administration and Andrea Deane and Anne Gilbert from APrON study
team for administering the survey. We also wish to extend our sincere
appreciation to the APrON study families and research team for their
support and participation in this research. The individual members of
the APrON research team are Nicole Letourneau, Catherine J. Field,
Deborah Dewey, Rhonda C. Bell, Francois P. Bernier, Marja Cantell,
Linda M. Casey, Misha Eliasziw, Anna Farmer, Lisa Gagnon, Gerald F.
Giesbrecht, Laki Goonewardene, David W. Johnston, Bonnie J. Kaplan,
Libbe Kooistra, Brenda MY Leung, Donna P. Manca, Jonathan W. Martin,Linda J. McCargar, Maeve O’Beirne, Victor J. Pop, Nalini Singhal. At the
time of the research MBA held a Banting Postdoctoral Fellowship and
was supported by Alberta Innovates - Health Solutions. ALK held a
Research Chair supported by the Women and Children's Health Research
Institute/Stollery Children's Hospital Foundation.
Author details
1Department of Pediatrics, University of Alberta, Edmonton, Canada.
2Department of Agriculture, Food & Nutritional Science, University of Alberta,
Edmonton, Canada. 3Faculties of Nursing & Medicine (Pediatrics), Calgary,
Canada. 4Department of Pediatrics, Alberta Children’s Hospital, Calgary,
Canada.
Received: 16 July 2014 Accepted: 27 August 2014
Published: 29 September 2014References
1. Sommer F, Backhed F: The gut microbiota–masters of host development
and physiology. Nat Rev Microbiol 2013, 11:227–238.
2. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S:
Host-gut microbiota metabolic interactions. Science 2012, 336:1262–1267.
3. Tremaroli V, Backhed F: Functional interactions between the gut
microbiota and host metabolism. Nature 2012, 489:242–249.
4. Food and Agriculture Organization of the United Nations (FAO): Health and
nutritional properties of probiotics in food including powder milk with live
lactic acid bacteria. Argentina: Food and Agriculture Organization of the
United Nations (FAO); 2001.
5. Vandenplas Y, De Greef E, Devreker T, Veereman-Wauters G, Hauser B:
Probiotics and prebiotics in infants and children. Curr Infect Dis Rep
2013, 15:251–262.
6. Marchand V: Using probiotics in the paediatric population. Paediatr Child
Health 2012, 17:575–576.
7. Azad MB, Coneys JG, Kozyrskyj AL, Field CJ, Ramsey CD, Becker AB, Friesen C,
Abou-Setta AM, Zarychanski R: Probiotic supplementation during pregnancy
or infancy for the prevention of asthma and wheeze: systematic review and
meta-analysis. BMJ 2013, 347:6471.
8. Thomas DW, Greer FR: Probiotics and prebiotics in pediatrics.
Pediatrics 2010, 126:1217–1231.
9. Weichert S, Schroten H, Adam R: The role of prebiotics and probiotics in
prevention and treatment of childhood infectious diseases. Pediatr Infect
Dis J 2012, 31:859–862.
10. Sanders ME, Guarner F, Guerrant R, Holt PR, Quigley EM, Sartor RB, Sherman PM,
Mayer EA: An update on the use and investigation of probiotics in health
and disease. Gut 2013, 62:787–796.
11. Boyle RJ, Robins-Browne RM, Tang ML: Probiotic use in clinical practice:
what are the risks? Am J Clin Nutr 2006, 83:1256–1264.
12. van den Nieuwboer M, Claassen E, Morelli L, Guarner F, Brummer RJ:
Probiotic and synbiotic safety in infants under two years of age.
Benef Microbes 2014, 5:45–60.
13. Braegger C, Chmielewska A, Decsi T, Kolacek S, Mihatsch W, Moreno L,
Piescik M, Puntis J, Shamir R, Szajewska H, Turck D, van Goudoever J:
Supplementation of infant formula with probiotics and/or prebiotics: a
systematic review and comment by the ESPGHAN committee on
nutrition. J Pediatr Gastroenterol Nutr 2011, 52:238–250.
14. Jeurink PV, van Bergenhenegouwen J, Jimenez E, Knippels LM, Fernandez L,
Garssen J, Knol J, Rodriguez JM, Martin R: Human milk: a source of more
life than we imagine. Benef Microbes 2013, 4:17–30.
15. Kaplan BJ, Giesbrecht GF, Leung BM, Field CJ, Dewey D, Bell RC, Manca DP,
O’Beirne M, Johnston DW, Pop VJ, Singhal N, Gagnon L, Bernier FP,
Eliasziw M, McCargar LJ, Kooistra L, Farmer A, Cantell M, Goonewardene L,
Casey LM, Letourneau N, Martin JW: The Alberta Pregnancy Outcomes and
Nutrition (APrON) cohort study: rationale and methods. Matern Child Nutr
2014, 10:44–60.
16. Harrison KL, Farrell RM, Brinich MA, Highland J, Mercer M, McCormick JB,
Tilburt J, Geller G, Marshall P, Sharp RR: ‘Someone should oversee it’:
patient perspectives on the ethical issues arising with the regulation of
probiotics. Health Expect 2012, in press.
17. Mercer M, Brinich MA, Geller G, Harrison K, Highland J, James K, Marshall P,
McCormick JB, Tilburt J, Achkar JP, Farrell RM, Sharp RR: How patients view
probiotics: findings from a multicenter study of patients with
Bridgman et al. BMC Complementary and Alternative Medicine 2014, 14:366 Page 9 of 9
http://www.biomedcentral.com/1472-6882/14/366inflammatory bowel disease and irritable bowel syndrome. J Clin
Gastroenterol 2012, 46:138–144.
18. Wadhera V, Lemberg DA, Leach ST, Day AS: Complementary and
alternative medicine in children attending gastroenterology clinics:
usage patterns and reasons for use. J Paediatr Child Health 2011,
47:904–910.
19. Sesham R, Oddie S, Embleton ND, Clarke P: Probiotics for preterm
neonates: parents’ perspectives and present prevalence. Arch Dis
Child Fetal Neonatal Ed 2014, doi:10.1136/archdischild-2014-306344.
[Epub ahead of print].
20. Sharp RR, Achkar JP, Brinich MA, Farrell RM: Helping patients make
informed choices about probiotics: a need for research. Am J
Gastroenterol 2009, 104:809–813.
21. Gerritsen J, Smidt H, Rijkers GT, de Vos WM: Intestinal microbiota in human
health and disease: the impact of probiotics. Genes Nutr 2011, 6:209–240.
22. Fouhy F, Guinane CM, Hussey S, Wall R, Ryan CA, Dempsey EM, Murphy B,
Ross RP, Fitzgerald GF, Stanton C, Cotter PD: High-throughput sequencing
reveals the incomplete, short-term recovery of infant gut microbiota
following parenteral antibiotic treatment with ampicillin and gentamicin.
Antimicrob Agents Chemother 2012, 56:5811–5820.
23. Azad MB, Konya T, Maughan H, Guttman DS, Field CJ, Chari RS, Sears MR,
Becker AB, Scott JA, Kozyrskyj AL: Gut microbiota of healthy Canadian
infants: profiles by mode of delivery and infant diet at 4 months.
CMAJ 2013, 185:385–394.
24. Salminen S, Gibson GR, McCartney AL, Isolauri E: Influence of mode of
delivery on gut microbiota composition in seven year old children.
Gut 2004, 53:1388–1389.
25. Gronlund MM, Lehtonen OP, Eerola E, Kero P: Fecal microflora in healthy
infants born by different methods of delivery: permanent changes in
intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr 1999,
28:19–25.
26. Cook C, Health F, Thompson RL: A meta-analysis of response rates in
web- or internet-based surveys. Educ Psychol Meas 2000, 60:821–836.
27. Sanchez-Fernandez J, Munoz-Leiva F, Montoro-Rios FJ: Improving retention
rate and response quality in Web-based surveys. Comput Hum Behav
2012, 28:507–514.
28. Fan WM, Yan Z: Factors affecting response rates of the web survey: A
systematic review. Comput Hum Behav 2010, 26:132–139.
29. Seward R, Stanley-Stevens L: Fathers, fathering, and fatherhood across
cultures. In Parenting Across Cultures. Edited by Selin HNY. Dordrecht:
Springer; 2014:459–474.
doi:10.1186/1472-6882-14-366
Cite this article as: Bridgman et al.: Maternal perspectives on the use of
probiotics in infants: a cross-sectional survey. BMC Complementary and
Alternative Medicine 2014 14:366.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
